C-Suite Shake Up: How Paul Clancy Jumping Ship Affects Alexion, Biogen
June 15, 2017 at 09:26 AM EDT
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced Wednesday the appointment of Paul Clancy as its chief financial officer, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.